You can buy or sell FibroGen and other stocks, options, ETFs, and crypto commission-free!
FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics. It focuses on hypoxia-inducible factor and connective tissue growth factor biology to develop innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Read More The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.
San Francisco, California
52 Week High
52 Week Low
Expected Nov 7, After Hours